• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Coca-Cola Europacific Partners plc

    5/22/25 12:21:27 PM ET
    $CCEP
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $CCEP alert in real time by email
    6-K 1 a20250522ccepform6-kresult.htm 6-K Document

    United States
    Securities and Exchange Commission
    Washington, D.C. 20549
    FORM 6-K
    Report of Foreign Private Issuer
    Pursuant to Rule 13a-16 or 15d-16
    under the Securities Exchange Act of 1934

    May 22, 2025

    Commission File Number 001-37791
    COCA-COLA EUROPACIFIC PARTNERS PLC
    Pemberton House, Bakers Road
    Uxbridge, UB8 1EZ, United Kingdom

    (Address of principal executive office)
    (Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
    (Check One) Form 20-F ý Form 40-F D ¨




    cceuropacificp_logo.jpg

    22 May 2025

    Coca-Cola Europacific Partners plc – Results of 2025 Annual General Meeting

    The Annual General Meeting of Coca-Cola Europacific Partners plc (the “Company”) was held at Pemberton House, Bakers Road, Uxbridge, UB8 1EZ, United Kingdom on 22 May 2025.

    All 29 resolutions put to the members were passed on a poll. Accordingly, resolutions 1 to 24 were passed as ordinary resolutions and resolutions 25 to 29 were passed as special resolutions.

    The results of the polls are set out below:

    ResolutionFor (see note 1)Against (see note 1)Issued share capital represented by votes (see note 2) %Votes withheld (see note 3)
    Votes%Votes%
    1Receipt of the Report and Accounts411,028,90599.9934,530089.66206,410
    2Approval of the Directors’ Remuneration Report407,667,90899.143,521,7420.8589.69
    80,195
    3Election of Sol Daurella as a director of the Company376,687,04891.6134,486,2188.3889.6996,579
    4Election of Robert Appleby as a director of the Company408,483,42599.332,714,5980.6689.6971,822
    5Re-election of Manolo Arroyo as a director of the Company336,109,23981.9274,169,23718.0789.49991,369
    6Re-election of Guillaume Bacuvier as a director of the Company408,686,56299.392,487,9110.689.6995,372
    7Re-election of John Bryant as a director of the Company401,092,67097.5410,105,0292.4589.6972,146
    8Re-election of José Ignacio Comenge as a director of the Company351,104,55385.5759,174,06114.4289.49991,231
    9Re-election of Damian Gammell as a director of the Company408,575,61399.362,597,4340.6389.6996,798
    10Re-election of Nathalie Gaveau as a director of the Company409,909,70399.691,264,8460.389.6995,296
    11Re-election of Álvaro Gómez-Trénor Aguilar as a director of the Company405,092,97498.545,994,2151.4589.67182,656
    12Re-election of Mary Harris as a director of the Company380,238,30092.4830,884,1777.5189.68147,368
    2

    cceuropacificp_logo.jpg
    13Re-election of Thomas H. Johnson as a director of the Company372,883,40290.6938,239,4759.389.68146,968
    14Re-election of Alfonso Líbano Daurella as a director of the Company405,640,87398.675,446,8161.3289.67182,156
    15Re-election of Nicolas Mirzayantz as a director of the Company408,882,60199.432,315,8170.5689.6971,427
    16Re-election of Mark Price as a director of the Company389,084,80594.6322,036,0925.3689.68148,948
    17Re-election of Nancy Quan as a director of the Company404,686,85498.446,402,0801.5589.67180,911
    18Re-election of Mario Rotllant Solá as a director of the Company404,098,42598.296,988,9141.789.67182,506
    19Re-election of Dessi Temperley as a director of the Company409,950,89299.691,246,1790.389.6972,774
    20Reappointment of the Auditor408,882,04199.492,067,7540.589.64320,050
    21Remuneration of the Auditor410,236,44999.76967,2590.2389.6966,137
    22Political donations409,602,53199.631,487,3750.3689.67179,939
    23Authority to allot new shares403,667,47298.177,511,1001.8289.6991,273
    24Waiver of mandatory offer provisions set out in Rule 9 of the Takeover Code (see note 5)183,524,50074.9561,313,60525.0453.41166,431,740
    25General authority to disapply pre-emption rights405,714,73598.94,505,8081.0989.481,049,302
    26General authority to disapply pre-emption rights in connection with an acquisition or specified capital investment409,734,86499.82718,5100.1789.53816,471
    27Authority to purchase own shares on market407,902,92599.223,197,4380.7789.67169,482
    3

    cceuropacificp_logo.jpg
    28Authority to purchase own shares off market403,599,66598.227,309,5601.7789.63360,620
    29Notice period for general meetings other than annual general meetings404,754,79998.436,435,8571.5689.6979,189

    The results for the election and re-election of independent non-executive directors, excluding the votes cast by Olive Partners, S.A. as the Company’s controlling shareholder, are set out below (see note 4):

    ResolutionFor (see note 4)Against (see note 4)Issued share capital represented by votes%Votes withheld (see note 3)
    Votes%Votes%
    4Election of Robert Appleby as a director of the Company242,354,43998.892,714,5981.153.4671,822
    6Re-election of Guillaume Bacuvier as a director of the Company242,557,57698.982,487,9111.0153.4595,372
    7Re-election of John Bryant as a director of the Company234,963,68495.8710,105,0294.1253.4672,146
    10Re-election of Natalie Gaveau as a director of the Company243,780,71799.481,264,8460.5153.4595,296
    12Re-election of Mary Harris as a director of the Company214,109,31487.3930,884,17712.653.44147,368
    13Re-election of Thomas H. Johnson as a director of the Company206,754,41684.3938,239,47515.653.44146,968
    15Re-election of Nicolas Mirzayantz as a director of the Company242,753,61599.052,315,8170.9453.4671,427
    4

    cceuropacificp_logo.jpg
    16Re-election of Mark Price as a director of the Company222,955,8199122,036,0928.9953.44148,948
    19Re-election of Dessi Temperley as a director of the Company243,821,90699.491,246,1790.553.4672,774


    Notes:
    1Votes “For” and “Against” are expressed as a percentage of votes received.
    2As at 3:30pm on Tuesday 20 May 2025, the time by which shareholders who wanted to attend, speak and vote at the AGM must have been entered on the Company’s register of members, there were 458,454,255 ordinary shares in issue.
    3A “Vote Withheld” is not a vote in law and is not counted in the calculation of the proportion of votes “For” or “Against” a resolution.
    4
    Under the UK Listing Rules (the “UKLR”), Olive Partners, S.A. (“Olive”) is treated as a “controlling shareholder” of the Company (that is, it exercises or controls more than 30% of the voting rights of the Company). In accordance with UKLR 6.2.5R, the election and re-election of CCEP’s independent non-executive directors must be conducted in accordance with UKLR 6.2.8R and 6.2.9R. Accordingly, the votes by CCEP’s shareholders excluding Olive and its presumed concert parties (the “Independent Shareholders”) in respect of resolutions 4, 6, 7, 10, 12, 13, 15, 16 and 19 have been counted and set out separately to determine whether these resolutions have been approved by a majority of the Independent Shareholders.

    5Resolution 24 was put to the AGM as a resolution of the Independent Shareholders.

    Resolution 24, being the ordinary resolution to approve the waiver by the Panel on Takeovers and Mergers under Rule 9 of the City Code on Takeovers and Mergers (the “Rule 9 Waiver”) in connection with the Company’s buyback programme, was duly passed by 74.95% of the votes cast by the Independent Shareholders with 25.04% of votes cast against. Resolution 24 is a standing agenda item at each Annual General Meeting to enable CCEP to exercise the authorities under resolution 27 to purchase its own shares on market and resolution 28 to purchase its own shares off market, which were passed with majorities of 99.22% and 98.22% respectively. This will enable CCEP to make use of the option to return value to shareholders through a possible future buyback programme. Had resolution 24 not been passed, the Company would not have been able to effect such buyback programmes, as explained in the Notice of AGM and also in the Letter to Shareholders issued via RNS on 12 May 2025.

    CCEP intends to continue to engage with ISS on their standing policy to generally recommend a vote against Rule 9 waivers, which we believe may be a contributing factor in influencing investor decisions in this regard. In addition, CCEP will continue to engage, in the normal course and as appropriate, with shareholders who did not support resolution 24 to understand the reasons for their vote against the proposal and to continue a transparent and constructive dialogue on this topic. In accordance with provision 4 of the UK Corporate Governance Code, the Company will publish an update on this
    5

    cceuropacificp_logo.jpg
    engagement, in accordance with the UK Corporate Governance Code, within six months of the 2025 AGM and a final summary in the Company's Annual Report for the 2025 Financial Year.


    Olive is currently interested in 166,128,987 shares in the Company and the Rule 9 Waiver does not entitle Olive to be interested in a greater number of shares. The Rule 9 Waiver would allow Olive’s interest in shares as a percentage of the Company’s total shares to increase as a result of the exercise of the Company’s authorities to purchase its own shares, but only to the extent that the resulting interest of Olive, together with any concert parties, in the shares of the Company did not then exceed 40.1137%.

    In accordance with UK Listing Rule 6.4.2R, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.


    CONTACTS
    Company Secretariat
    Clare Wardle

    T +44 (0)20 7355 8406
    Investor Relations
    Sarah Willett

    T +44 (0)7970 145 218
    Media Relations
    Shanna Wendt

    T +44 (0)7976 595 168



    ABOUT CCEP

    Coca-Cola Europacific Partners is one of the world’s leading consumer goods companies. We make, move and sell some of the world’s most loved brands – serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

    We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

    The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP.

    For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

    6


    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    COCA-COLA EUROPACIFIC PARTNERS PLC
    (Registrant)
    Date: May 22, 2025By:
    /s/ Clare Wardle
    Name:Clare Wardle
    Title:General Counsel & Company Secretary

    7
    Get the next $CCEP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCEP

    DatePrice TargetRatingAnalyst
    2/25/2025Hold → Reduce
    Kepler
    12/9/2024Equal-Weight → Overweight
    Morgan Stanley
    12/3/2024$82.00Mkt Perform
    Bernstein
    11/27/2024$85.00 → $82.00Overweight → Neutral
    Analyst
    9/10/2024$81.00Outperform → Neutral
    Exane BNP Paribas
    1/12/2024Neutral → Outperform
    Exane BNP Paribas
    12/4/2023Neutral → Buy
    Goldman
    4/26/2023$61.15Sell → Hold
    Societe Generale
    More analyst ratings